Healthcare

Falling demand sees J&J scale back COVID-19 vaccine

Falling demand sees J&J scale back COVID-19 vaccine

Pharmaphorum, January 16, 2023

With demand for its COVID-19 vaccine decreasing, Johnson & Johnson (J&J) has begun scaling back production of the shots. In the past few months, the New Brunswick, New Jersey-based pharmaceutical company has terminated manufacturing agreements with companies that helped to produce the vaccine during the pandemic, including Catalent and Sanofi.

 

Covid lockdowns were not necessarily a ‘net negative’

Covid lockdowns were not necessarily a ‘net negative’

The Washington Post, January 8, 2023

This book on men has a vital message and a model to follow,” Mitch Daniels’s Jan. 4 op-ed on the recent reissuance of the book, “Men Without Work: America’s Invisible Crisis,” was thoughtful. But he violated his own message of considering various perspectives without declaring certainty in his main example regarding the Great Barrington Declaration signers. His conclusion that “the condemnation they incurred was profoundly anti-intellectual and anti-scientific” was defensible, but his declaration that pandemic lockdown policies were unequivocally a “net negative” was not, as it was implicitly predicated on how objectives are weighted.

Media Contact

Ashley Smith
Public Affairs Coordinator
INFORMS
Catonsville, MD
[email protected]
443-757-3578

See all Categories